HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of preoperative itraconazole in allergic fungal rhinosinusitis.

AbstractINTRODUCTION:
Criterion standard treatment of allergic fungal sinusitis (AFS) is primary surgery followed by adjuvant therapy. Even after good surgery, recurrence rates vary from 10 to 79%. Antifungals, e.g., itraconazole, and steroids have shown varying success rates in delaying recurrences given after surgery. Itraconazole decreases the need for steroids given as a primary treatment in allergic bronchopulmonary aspergillosis. This study investigated the efficacy of itraconazole given preoperatively for allergic fungal rhinosinusitis.
METHODOLOGY:
A prospective study was carried out from July 2011 to November 2013 with 27 patients with histologically proven AFS, who were given itraconazole for 1 month in the preoperative period and operated after completion of the course of itraconazole. They were compared with 25 matched controls of patients with AFS who were operated on directly without preoperative itraconazole. Both groups were given oral steroids in tapering doses for 6 weeks during the postoperative period and followed up at regular intervals. Evaluations were done by using symptomatic (Sino-Nasal Outcome Test [SNOT-20]), radiologic (Lund Mackay scores), and endoscopic (Kupferberg nasal endoscopic grades) parameters.
RESULTS:
Symptomatology scores (SNOT-20) decreased significantly (p = 0.000) with itraconazole. There was a decrease (p = 0.007) in the Lund Mackay scores that reached up to 0. There was complete resolution of disease in 15% of the patients. Reductions in hyperdensities were noted on computed tomography in all the patients after preoperative itraconazole. Polyp sizes decreased and nasal endoscopic grades improved after itraconazole. Postoperative fungal cultures were positive in 60% of the patients in the preoperative itraconazole group compared with 76% of the patients in the control group, which indicated a decreased fungal burden.
CONCLUSION:
We found improvements in clinical, radiologic, and endoscopic parameters in AFS after preoperative itraconazole administration, which decreased the disease load significantly and also reduced the extent of surgery in the short-term follow-up. It may prove to be a good preoperative adjunct that needs further research.
AuthorsSourabha K Patro, Roshan K Verma, Naresh K Panda, Arunaloke Chakrabarti, Paramjeet Singh
JournalAmerican journal of rhinology & allergy (Am J Rhinol Allergy) 2015 Jul-Aug Vol. 29 Issue 4 Pg. 299-304 ISSN: 1945-8932 [Electronic] United States
PMID26163250 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Antifungal Agents
  • Itraconazole
Topics
  • Adult
  • Antifungal Agents (administration & dosage)
  • Female
  • Follow-Up Studies
  • Hospitals, University
  • Humans
  • Itraconazole (administration & dosage)
  • Male
  • Middle Aged
  • Mycoses (complications)
  • Preoperative Care
  • Prospective Studies
  • Recurrence
  • Rhinitis, Allergic (drug therapy, microbiology, surgery)
  • Sinusitis (drug therapy, microbiology, surgery)
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: